Ophthalmology and Optometry

Optometry and Vision Science session deals with vision care, including refraction, contact lenses, and low vision rehabilitation. Topics include advancements in corrective lenses, myopia control, and binocular vision disorders. Visual ergonomics and digital eye strain management will also be discussed. Emerging trends like orthokeratology and behavioral optometry will feature prominently. Researchers will present findings on vision therapy and pediatric eye care. The session will connect clinical practice with research in visual perception. Practical workshops on optometric equipment and technologies are expected.

This track will focus on eye conditions in infants and children, including amblyopia, strabismus, and congenital cataracts. Management strategies for early detection and intervention will be discussed. The role of genetics in pediatric eye diseases will be examined. Recent developments in surgical techniques for young patients will be highlighted. Challenges in pediatric vision screening programs across populations will be reviewed. Insights into pediatric refractive errors and visual development will be shared. Case studies and new diagnostic approaches will enrich this session.

Optometry and Vision Science session deals with vision care, including refraction, contact lenses, and low vision rehabilitation. Topics include advancements in corrective lenses, myopia control, and binocular vision disorders. Visual ergonomics and digital eye strain management will also be discussed. Emerging trends like orthokeratology and behavioral optometry will feature prominently. Researchers will present findings on vision therapy and pediatric eye care. The session will connect clinical practice with research in visual perception. Practical workshops on optometric equipment and technologies are expected.

This track addresses retinal diseases such as diabetic retinopathy, macular degeneration, and retinal detachment. Advances in anti-VEGF therapies and laser treatments will be discussed. Experts will highlight imaging modalities like fundus photography and OCT angiography. Gene therapy for inherited retinal diseases will be a special focus. The impact of systemic diseases like diabetes on retinal health will be explored. Artificial retina technology and prostheses development will also feature. Patient management strategies and surgical innovations will be shared.

This session delves into corneal infections, dystrophies, and keratoconus. Innovations in corneal transplantation, including DMEK and DSAEK, will be presented. Researchers will share developments in bioengineered corneas and regenerative medicine. Diagnosis and management of dry eye disease and ocular surface disorders will be explored. Contact lens-related complications and their prevention will be reviewed. The role of UV exposure and environment in corneal pathologies will be discussed. Therapeutic approaches like cross-linking and customized treatments will be covered.

Cataract track will highlight surgical innovations like femtosecond laser-assisted cataract surgery. Focus will be on premium intraocular lenses (IOLs) and personalized lens selection. Preoperative evaluation and biometry techniques will be shared. Complication management and post-surgical care will also be discussed. Emerging trends in cataract surgery in developing countries will be reviewed. Experts will discuss patient satisfaction and visual outcomes. Integration of AI for surgical planning will be an exciting highlight.

This session covers ocular surface tumors, uveal melanoma, and retinoblastoma. Focus will be on molecular diagnostics and personalized therapy for ocular cancers. Surgical and radiation treatment updates will be shared. Research on targeted drug therapies and immunotherapies will be discussed. Genetic risk factors and screening guidelines will be reviewed. New developments in imaging for ocular tumor detection will be explored. Multidisciplinary approaches in managing ocular malignancies will be emphasized.

The Neuro-Ophthalmology track will cover visual pathway disorders, optic neuropathies, and eye movement abnormalities. Discussions will highlight multiple sclerosis-related visual issues. New diagnostic imaging techniques such as MRI and OCT in neuro-ophthalmology will be reviewed. Experts will discuss management of diplopia and nystagmus. The session will address cerebrovascular and neurodegenerative impacts on vision. Pharmacological and surgical interventions for neural disorders will be shared. Case reports and challenging diagnostic scenarios will enrich this session.

This track focuses on eyelid, orbit, and lacrimal system disorders. Techniques in blepharoplasty, ptosis correction, and orbital decompression will be discussed. Innovations in reconstructive surgery post-tumor excision will be covered. Management of traumatic injuries and congenital anomalies will be shared. Aesthetic oculoplastic procedures and outcomes will be reviewed. Integration of 3D imaging in surgical planning will be explored. Patient-reported outcomes and satisfaction metrics will be emphasized.

Refractive surgery updates, including LASIK, SMILE, and PRK, will be covered. Focus will be on patient selection and outcomes analysis. Advances in corneal mapping and wavefront technology will be discussed. Complications like ectasia and dry eye post-surgery will be reviewed. Customized ablation profiles and presbyopia correction will be explored. Long-term efficacy and safety studies will be presented. Future trends in non-invasive refractive corrections will be highlighted.

Uveitis pathogenesis, diagnosis, and management will be discussed in detail. Focus on autoimmune causes and infectious uveitis will be included. Systemic associations like sarcoidosis and Behçet’s disease will be explored. New immunosuppressive and biologic therapies will be shared. Advances in imaging for uveitis monitoring will be reviewed. Complications such as glaucoma and cataract in uveitis patients will be addressed. Case-based discussions on complex presentations will be featured.

The role of AI in early diagnosis and prognosis of eye diseases will be explored. Automated screening tools for diabetic retinopathy and glaucoma will be highlighted. Machine learning models for surgical outcome prediction will be discussed. Integration of AI in ophthalmic imaging interpretation will be reviewed. Ethical concerns and challenges in AI deployment will be debated. Collaborative AI-human decision-making in clinics will be emphasized. Future perspectives on AI-driven personalized care will be shared.

Genetic basis of inherited retinal diseases will be the focus of this track. Recent successes in gene therapy for Leber congenital amaurosis and RP will be discussed. CRISPR and gene editing technologies in ophthalmology will be reviewed. Genetic counseling for patients and families will be emphasized. Advances in molecular diagnostics for ocular conditions will be shared. Research on stem cell-based therapies for retinal repair will be presented. Challenges in clinical translation and regulatory issues will be debated.

This session covers strategies for managing visual impairment and blindness. Advances in low vision aids and assistive technologies will be shared. Rehabilitation programs for macular degeneration and glaucoma patients will be discussed. Psychological impact and counseling approaches will be emphasized. Innovations in mobility training and orientation techniques will be reviewed. Case studies of successful vision rehabilitation will be presented. Policy and advocacy for the visually impaired community will be explored.

Ocular pharmacokinetics and drug delivery systems will be the focus here. Innovations in topical, injectable, and implantable drug formulations will be reviewed. Challenges in drug penetration and bioavailability in the eye will be discussed. Nanotechnology-based ocular drug delivery will be highlighted. Emerging therapies for AMD, glaucoma, and uveitis will be shared. Controlled release systems and biodegradable implants will be explored. Regulatory aspects of new ophthalmic drugs will also feature.

Etiology and management of dry eye disease will be discussed comprehensively. Advances in tear film assessment and diagnostic tools will be reviewed. Therapeutic approaches including artificial tears and anti-inflammatory agents will be covered. Role of environmental and occupational factors in dry eye prevalence will be explored. Surgical options like punctal plugs and tarsorrhaphy will be highlighted. Impact of screen time and digital devices on ocular surface health will be shared. Future directions in personalized dry eye therapy will be presented.

Advances in contact lens materials and designs will be reviewed. Discussion on specialty lenses for keratoconus and myopia control will be included. Contact lens-related infections and prevention strategies will be shared. Innovations in smart contact lenses for drug delivery and monitoring will be explored. Impact of lens wear on ocular surface health will be discussed. Case reports on complex contact lens fittings will be presented. Safety standards and patient education practices will be emphasized.

Relationship between systemic diseases and ocular manifestations will be examined. Focus on diabetes, hypertension, and autoimmune disorders impacting the eye will be covered. Diagnostic challenges in systemic-associated ocular conditions will be shared. Multidisciplinary care approaches involving internists and ophthalmologists will be reviewed. Emerging data on COVID-19-related ocular effects will be discussed. Case-based learning on complex systemic-ocular cases will be presented. Therapeutic implications and coordination of care will be emphasized.